RNS
IMGN

Robert N. Shapiro’s Immunogen Inc IMGN Stock Holding History

Robert N. Shapiro’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,510
Closed -$26K – 932
2013
Q3 		$26K Hold
1,510
– – ﹤0.01% 743
2013
Q2 		$25K Buy
+1,510
New +$24.5K 0.01% 703

Other funds holding IMGN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Robert N. Shapiro's IMGN Position: Q4 2013 in Review

Robert N. Shapiro sold out of Immunogen Inc (IMGN) in Q4 2013, closing a stake of 1,510 shares — an estimated $26K sold.

Robert N. Shapiro first reported a position in IMGN in Q2 2013 and held it in 2 quarters. The position peaked at $26K in Q3 2013. 135 funds tracked by Wall St. Rank hold IMGN as of Q4 2013.

  • Robert N. Shapiro reported no remaining Immunogen Inc position as of Q4 2013 after selling out during the quarter.
  • Robert N. Shapiro sold 1,510 Immunogen Inc shares in Q4 2013, an estimated $26K.
  • Robert N. Shapiro first reported a position in Immunogen Inc in Q2 2013 and held it in 2 quarters.
  • Robert N. Shapiro's Immunogen Inc position peaked at $26K in Q3 2013.
  • 135 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2013.

Based on Robert N. Shapiro's 13F filing for Q4 2013, filed 6 Feb 2014.